The impact of the COVID-19 pandemic on the emotional well-being and home treatment of Belgian patients with cystic fibrosis, including transplanted patients and paediatric patients

RECOMMENDED

ARDSCoughPulmonary Fibrosis

First Wave of COVID-19 in French Patients with Cystic Fibrosis

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

J Clin Med

Corvol H, de Miranda S, Lemonnier L, Kemgang A, Reynaud Gaubert M, Chiron R, Dalphin ML, Durieu I, Dubus JC, Houdouin V, Prevotat A, Ramel S, Revillion M, Weiss L, Guillot L, Boelle PY, Burgel PR

doi: 10.3390/jcm9113624

RECOMMENDED

Pulmonary Fibrosis

Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey

★ 2 Recommended by Dr Martin Frey, Faculty Member

Respir Med.

Mondejar-Lopez P, Quintana-Gallego E, Giron-Moreno RM, Cortell-Aznar I, Ruiz de Valbuena-Maiz M, Diab-Caceres L, Prados-Sanchez C, Alvarez-Fernandez A, Garcia-Marcos PW, Peñalver-Mellado C, Pastor-Vivero MD, Olveira C, Lopez-Neyra A, Castillo-Corullon S, Palma-Milla S, Perez-Ruiz E, Sole-Jover A, Barrio MI, Sanchez-Solis M, Asensio de la Cruz Ó, CF-COVID19-Spain Registry Group

doi: 10.1016/j.rmed.2020.106062.

RECOMMENDED

Sleep Apnea

Impact of the novel coronavirus disease (COVID-19) on treatment adherence and sleep duration in patients with obstructive sleep apnea treated with positive airway pressure

★ 1 Recommended by Dr Martin Frey, Faculty Member

J Clin Sleep Med.

Batool-Anwar S, Omobomi OS, Quan SF

doi: 10.5664/jcsm.8746.

RECOMMENDED

Pulmonary Fibrosis

Effect of the COVID-19 pandemic on anxiety among children with cystic fibrosis and their mothers

★ 2 Recommended by Dr Martin Frey, Faculty Member

Pediatr Pulmonol.

Senkalfa BP, Eyuboglu TS, Aslan AT, Gursoy TR, Soysal AS, Yapar D, İlhan MN

doi: 10.1002/ppul.24900.

RECOMMENDED

Respiratory Tract Infection

Neutralizing Antibody Production in Asymptomatic and Mild COVID-19 Patients, in Comparison with Pneumonic COVID-19 Patients

★ 2 Recommended by Dr Martin Frey, Faculty Member

J Clin Med.

Ko JH, Joo EJ, Park SJ, Baek JY, Kim WD, Jee J, Kim CJ, Jeong C, Kim YJ, Shon HJ, Kang ES, Choi YK, Peck KR

doi: 10.3390/jcm9072268.

RECOMMENDED

Further Publications

Outpatient Management of Patients With COVID-19: Multicenter Prospective Validation of the HOME-CoV Rule to safely discharge patients

★ 3 Recommended by Dr Martin Frey, Faculty Member

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

Chest

Douillet D, Penaloza A, Mahieu R, Morin F, Chauvin A, Gennai S, Schotte T, Montassier E, Thiebaut PC, Ghuysen A, Dall'acqua D, Benhammouda K, Bissokele P, Violeau M, Joly LM, Andrianjafy H, Soulie C, Savary D, Riou J, Roy PM, HOME-CoV Study Group*.

doi: 10.1016/j.chest.2021.05.008

RECOMMENDED

Interstitial Lung Disease

Practical considerations for the diagnosis and treatment of fibrotic interstitial lung disease during the COVID-19 pandemic

★ 1 Recommended by Dr Martin Frey, Faculty Member

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

Chest.

Wong AW, Fidler L, Marcoux V, Johannson KA, Assayag D, Fisher JH, Hambly N, Kolb M, Morisset J, Shapera S, Ryerson CJ

doi: 10.1016/j.chest.2020.04.019.

Pulmonary Fibrosis

Impact of a cystic fibrosis transmembrane conductance regulator (CFTR) modulator on high-dose ibuprofen therapy in pediatric cystic fibrosis patients

Pediatr Pulmonol.

Bruch BA, Singh SB, Ramsey LJ, Starner TD

doi: 10.1002/ppul.24024.

First experience in Switzerland in Phe508del homozygous cystic fibrosis patients with end-stage pulmonary disease enrolled in a lumacaftor-ivacaftor therapy trial - preliminary results

Swiss Med Wkly.

Murer C, Huber LC, Kurowski T, Hirt A, Robinson CA, Bürgi U, Benden C

doi: 10.4414/smw.2018.14593.

Related content

First Wave of COVID-19 in French Patients with Cystic Fibrosis

Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey

Impact of the novel coronavirus disease (COVID-19) on treatment adherence and sleep duration in patients with obstructive sleep apnea treated with positive airway pressure

Effect of the COVID-19 pandemic on anxiety among children with cystic fibrosis and their mothers

Neutralizing Antibody Production in Asymptomatic and Mild COVID-19 Patients, in Comparison with Pneumonic COVID-19 Patients

Outpatient Management of Patients With COVID-19: Multicenter Prospective Validation of the HOME-CoV Rule to safely discharge patients

Practical considerations for the diagnosis and treatment of fibrotic interstitial lung disease during the COVID-19 pandemic

Impact of a cystic fibrosis transmembrane conductance regulator (CFTR) modulator on high-dose ibuprofen therapy in pediatric cystic fibrosis patients

First experience in Switzerland in Phe508del homozygous cystic fibrosis patients with end-stage pulmonary disease enrolled in a lumacaftor-ivacaftor therapy trial - preliminary results